Epitinib succinate
CAS: 2252334-12-4
Ref. 3D-CQD33412
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Product Information
Epitinib succinate is a potent and selective inhibitor of human epidermal growth factor receptor (EGFR) tyrosine kinase, which is overexpressed in many types of cancer. This Chinese analog of the anticancer drug Gefitinib has been shown to inhibit tumor growth and induce apoptosis in cancer cells. Epitinib succinate selectively inhibits EGFR kinases by binding to the ATP-binding site, leading to inhibition of downstream signaling pathways that promote cell proliferation and survival. This drug has been tested in preclinical studies and has shown promising results as a potential treatment for various types of cancer. Epitinib succinate can be detected in urine and is currently being investigated as a potential toxin for targeted cancer therapy.
Chemical properties
Technical inquiry about: 3D-CQD33412 Epitinib succinate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
